ACEP advocacy resulted in an additional $7.4 million in Substance Abuse and Mental Health Services Administration (SAMHSA) grant funding for Emergency Department Alternative to Opioids (ALTO) programs and an additional $18.4 million for programs providing Medication-Assisted Treatment (MAT).
ACEP developed, advocated for, and secured enactment of the law passed by Congress in 2018 to establish the ALTO grant program, and successfully advocated for follow-up legislation with a $2 million funding increase to make the emergency physician-led program permanent. We also strongly supported MAT expansion – including the recent repeal of the “X-waiver” to prescribe buprenorphine.
These latest grant awards are a strong example of the direct and ongoing impact and legacy of ACEP advocacy.
Related:
